Lower Back Pain Drug Market, Global Outlook and Forecast 2022-2028

June 2022 | 67 pages | ID: L30672978A7BEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Lower Back Pain Drug in Global, including the following market information:

Global Lower Back Pain Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lower Back Pain Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Acute Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lower Back Pain Drug include Pfizer, Johnson and Johnson, Sanofi, Endo Pharmaceuticals, Merck, Dr. Reddy’s Laboratories, Vertebral Technologies, Medtronic and Boston Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lower Back Pain Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lower Back Pain Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lower Back Pain Drug Market Segment Percentages, by Type, 2021 (%)

• Acute Drug
• Chronic Drug

Global Lower Back Pain Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lower Back Pain Drug Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Other

Global Lower Back Pain Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lower Back Pain Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lower Back Pain Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lower Back Pain Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Johnson and Johnson
• Sanofi
• Endo Pharmaceuticals
• Merck
• Dr. Reddy’s Laboratories
• Vertebral Technologies
• Medtronic
• Boston Scientific
• BioWave
• Koninklijke Philips
• Stayble Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lower Back Pain Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lower Back Pain Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LOWER BACK PAIN DRUG OVERALL MARKET SIZE

2.1 Global Lower Back Pain Drug Market Size: 2021 VS 2028
2.2 Global Lower Back Pain Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lower Back Pain Drug Players in Global Market
3.2 Top Global Lower Back Pain Drug Companies Ranked by Revenue
3.3 Global Lower Back Pain Drug Revenue by Companies
3.4 Top 3 and Top 5 Lower Back Pain Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lower Back Pain Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lower Back Pain Drug Players in Global Market
  3.6.1 List of Global Tier 1 Lower Back Pain Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lower Back Pain Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lower Back Pain Drug Market Size Markets, 2021 & 2028
  4.1.2 Acute Drug
  4.1.3 Chronic Drug
4.2 By Type - Global Lower Back Pain Drug Revenue & Forecasts
  4.2.1 By Type - Global Lower Back Pain Drug Revenue, 2017-2022
  4.2.2 By Type - Global Lower Back Pain Drug Revenue, 2023-2028
  4.2.3 By Type - Global Lower Back Pain Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lower Back Pain Drug Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Other
5.2 By Application - Global Lower Back Pain Drug Revenue & Forecasts
  5.2.1 By Application - Global Lower Back Pain Drug Revenue, 2017-2022
  5.2.2 By Application - Global Lower Back Pain Drug Revenue, 2023-2028
  5.2.3 By Application - Global Lower Back Pain Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lower Back Pain Drug Market Size, 2021 & 2028
6.2 By Region - Global Lower Back Pain Drug Revenue & Forecasts
  6.2.1 By Region - Global Lower Back Pain Drug Revenue, 2017-2022
  6.2.2 By Region - Global Lower Back Pain Drug Revenue, 2023-2028
  6.2.3 By Region - Global Lower Back Pain Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lower Back Pain Drug Revenue, 2017-2028
  6.3.2 US Lower Back Pain Drug Market Size, 2017-2028
  6.3.3 Canada Lower Back Pain Drug Market Size, 2017-2028
  6.3.4 Mexico Lower Back Pain Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lower Back Pain Drug Revenue, 2017-2028
  6.4.2 Germany Lower Back Pain Drug Market Size, 2017-2028
  6.4.3 France Lower Back Pain Drug Market Size, 2017-2028
  6.4.4 U.K. Lower Back Pain Drug Market Size, 2017-2028
  6.4.5 Italy Lower Back Pain Drug Market Size, 2017-2028
  6.4.6 Russia Lower Back Pain Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Lower Back Pain Drug Market Size, 2017-2028
  6.4.8 Benelux Lower Back Pain Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lower Back Pain Drug Revenue, 2017-2028
  6.5.2 China Lower Back Pain Drug Market Size, 2017-2028
  6.5.3 Japan Lower Back Pain Drug Market Size, 2017-2028
  6.5.4 South Korea Lower Back Pain Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Lower Back Pain Drug Market Size, 2017-2028
  6.5.6 India Lower Back Pain Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lower Back Pain Drug Revenue, 2017-2028
  6.6.2 Brazil Lower Back Pain Drug Market Size, 2017-2028
  6.6.3 Argentina Lower Back Pain Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lower Back Pain Drug Revenue, 2017-2028
  6.7.2 Turkey Lower Back Pain Drug Market Size, 2017-2028
  6.7.3 Israel Lower Back Pain Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Lower Back Pain Drug Market Size, 2017-2028
  6.7.5 UAE Lower Back Pain Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Lower Back Pain Drug Major Product Offerings
  7.1.4 Pfizer Lower Back Pain Drug Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Johnson and Johnson
  7.2.1 Johnson and Johnson Corporate Summary
  7.2.2 Johnson and Johnson Business Overview
  7.2.3 Johnson and Johnson Lower Back Pain Drug Major Product Offerings
  7.2.4 Johnson and Johnson Lower Back Pain Drug Revenue in Global Market (2017-2022)
  7.2.5 Johnson and Johnson Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Lower Back Pain Drug Major Product Offerings
  7.3.4 Sanofi Lower Back Pain Drug Revenue in Global Market (2017-2022)
  7.3.5 Sanofi Key News
7.4 Endo Pharmaceuticals
  7.4.1 Endo Pharmaceuticals Corporate Summary
  7.4.2 Endo Pharmaceuticals Business Overview
  7.4.3 Endo Pharmaceuticals Lower Back Pain Drug Major Product Offerings
  7.4.4 Endo Pharmaceuticals Lower Back Pain Drug Revenue in Global Market (2017-2022)
  7.4.5 Endo Pharmaceuticals Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Lower Back Pain Drug Major Product Offerings
  7.5.4 Merck Lower Back Pain Drug Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News
7.6 Dr. Reddy’s Laboratories
  7.6.1 Dr. Reddy’s Laboratories Corporate Summary
  7.6.2 Dr. Reddy’s Laboratories Business Overview
  7.6.3 Dr. Reddy’s Laboratories Lower Back Pain Drug Major Product Offerings
  7.6.4 Dr. Reddy’s Laboratories Lower Back Pain Drug Revenue in Global Market (2017-2022)
  7.6.5 Dr. Reddy’s Laboratories Key News
7.7 Vertebral Technologies
  7.7.1 Vertebral Technologies Corporate Summary
  7.7.2 Vertebral Technologies Business Overview
  7.7.3 Vertebral Technologies Lower Back Pain Drug Major Product Offerings
  7.7.4 Vertebral Technologies Lower Back Pain Drug Revenue in Global Market (2017-2022)
  7.7.5 Vertebral Technologies Key News
7.8 Medtronic
  7.8.1 Medtronic Corporate Summary
  7.8.2 Medtronic Business Overview
  7.8.3 Medtronic Lower Back Pain Drug Major Product Offerings
  7.8.4 Medtronic Lower Back Pain Drug Revenue in Global Market (2017-2022)
  7.8.5 Medtronic Key News
7.9 Boston Scientific
  7.9.1 Boston Scientific Corporate Summary
  7.9.2 Boston Scientific Business Overview
  7.9.3 Boston Scientific Lower Back Pain Drug Major Product Offerings
  7.9.4 Boston Scientific Lower Back Pain Drug Revenue in Global Market (2017-2022)
  7.9.5 Boston Scientific Key News
7.10 BioWave
  7.10.1 BioWave Corporate Summary
  7.10.2 BioWave Business Overview
  7.10.3 BioWave Lower Back Pain Drug Major Product Offerings
  7.10.4 BioWave Lower Back Pain Drug Revenue in Global Market (2017-2022)
  7.10.5 BioWave Key News
7.11 Koninklijke Philips
  7.11.1 Koninklijke Philips Corporate Summary
  7.11.2 Koninklijke Philips Business Overview
  7.11.3 Koninklijke Philips Lower Back Pain Drug Major Product Offerings
  7.11.4 Koninklijke Philips Lower Back Pain Drug Revenue in Global Market (2017-2022)
  7.11.5 Koninklijke Philips Key News
7.12 Stayble Therapeutics
  7.12.1 Stayble Therapeutics Corporate Summary
  7.12.2 Stayble Therapeutics Business Overview
  7.12.3 Stayble Therapeutics Lower Back Pain Drug Major Product Offerings
  7.12.4 Stayble Therapeutics Lower Back Pain Drug Revenue in Global Market (2017-2022)
  7.12.5 Stayble Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Lower Back Pain Drug Market Opportunities & Trends in Global Market
Table 2. Lower Back Pain Drug Market Drivers in Global Market
Table 3. Lower Back Pain Drug Market Restraints in Global Market
Table 4. Key Players of Lower Back Pain Drug in Global Market
Table 5. Top Lower Back Pain Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lower Back Pain Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lower Back Pain Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lower Back Pain Drug Product Type
Table 9. List of Global Tier 1 Lower Back Pain Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lower Back Pain Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lower Back Pain Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lower Back Pain Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lower Back Pain Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lower Back Pain Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lower Back Pain Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lower Back Pain Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lower Back Pain Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lower Back Pain Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lower Back Pain Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lower Back Pain Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lower Back Pain Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lower Back Pain Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lower Back Pain Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lower Back Pain Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lower Back Pain Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lower Back Pain Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lower Back Pain Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lower Back Pain Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lower Back Pain Drug Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Lower Back Pain Drug Product Offerings
Table 32. Pfizer Lower Back Pain Drug Revenue (US$, Mn), (2017-2022)
Table 33. Johnson and Johnson Corporate Summary
Table 34. Johnson and Johnson Lower Back Pain Drug Product Offerings
Table 35. Johnson and Johnson Lower Back Pain Drug Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Lower Back Pain Drug Product Offerings
Table 38. Sanofi Lower Back Pain Drug Revenue (US$, Mn), (2017-2022)
Table 39. Endo Pharmaceuticals Corporate Summary
Table 40. Endo Pharmaceuticals Lower Back Pain Drug Product Offerings
Table 41. Endo Pharmaceuticals Lower Back Pain Drug Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Lower Back Pain Drug Product Offerings
Table 44. Merck Lower Back Pain Drug Revenue (US$, Mn), (2017-2022)
Table 45. Dr. Reddy’s Laboratories Corporate Summary
Table 46. Dr. Reddy’s Laboratories Lower Back Pain Drug Product Offerings
Table 47. Dr. Reddy’s Laboratories Lower Back Pain Drug Revenue (US$, Mn), (2017-2022)
Table 48. Vertebral Technologies Corporate Summary
Table 49. Vertebral Technologies Lower Back Pain Drug Product Offerings
Table 50. Vertebral Technologies Lower Back Pain Drug Revenue (US$, Mn), (2017-2022)
Table 51. Medtronic Corporate Summary
Table 52. Medtronic Lower Back Pain Drug Product Offerings
Table 53. Medtronic Lower Back Pain Drug Revenue (US$, Mn), (2017-2022)
Table 54. Boston Scientific Corporate Summary
Table 55. Boston Scientific Lower Back Pain Drug Product Offerings
Table 56. Boston Scientific Lower Back Pain Drug Revenue (US$, Mn), (2017-2022)
Table 57. BioWave Corporate Summary
Table 58. BioWave Lower Back Pain Drug Product Offerings
Table 59. BioWave Lower Back Pain Drug Revenue (US$, Mn), (2017-2022)
Table 60. Koninklijke Philips Corporate Summary
Table 61. Koninklijke Philips Lower Back Pain Drug Product Offerings
Table 62. Koninklijke Philips Lower Back Pain Drug Revenue (US$, Mn), (2017-2022)
Table 63. Stayble Therapeutics Corporate Summary
Table 64. Stayble Therapeutics Lower Back Pain Drug Product Offerings
Table 65. Stayble Therapeutics Lower Back Pain Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Lower Back Pain Drug Segment by Type in 2021
Figure 2. Lower Back Pain Drug Segment by Application in 2021
Figure 3. Global Lower Back Pain Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lower Back Pain Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lower Back Pain Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lower Back Pain Drug Revenue in 2021
Figure 8. By Type - Global Lower Back Pain Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lower Back Pain Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lower Back Pain Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lower Back Pain Drug Revenue Market Share, 2017-2028
Figure 12. US Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lower Back Pain Drug Revenue Market Share, 2017-2028
Figure 16. Germany Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lower Back Pain Drug Revenue Market Share, 2017-2028
Figure 24. China Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lower Back Pain Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lower Back Pain Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lower Back Pain Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson and Johnson Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Endo Pharmaceuticals Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Dr. Reddy’s Laboratories Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Vertebral Technologies Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Medtronic Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Boston Scientific Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. BioWave Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Koninklijke Philips Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Stayble Therapeutics Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)